Skip to content
healthcare.dev

Tygacil

NDC 0008-4994, TIGECYCLINE, injection, powder, lyophilized, for solution, from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..

Product NDC
0008-4994
Status
Listed
Labeler
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021821
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0008-4994 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIGECYCLINE50 mg/5mL

Pharmacologic classes

Tetracycline-class Antibacterial [EPC]; Tetracyclines [CS]

Package NDCNDC-11Package
0008-4994-200000849942010 VIAL, SINGLE-DOSE in 1 CARTON (0008-4994-20) / 5 mL in 1 VIAL, SINGLE-DOSE (0008-4994-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fd826e47-1b77-4ffd-bb22-fda3379903b0
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0008-4994

Use it

Look up 0008-4994 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0008-4994 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0008-4994. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.